TKNO
Alpha Teknova, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$6.88
−4.97%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−40.1x
Market Cap
$369.38M
MomentumView details →
1D Return
−4.97%
YTD Return
+81.58%
RSI (14)
52.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−40.1x
Market Cap
$369.38M
RSI (14)
52.3
MomentumView details →
1D Return
−4.97%
YTD Return
+81.58%
SummaryUpdated Jun 1, 2026
Alpha Teknova, Inc. (NASDAQ:TKNO) is a California-based life sciences company founded in 1996 that provides critical reagents and laboratory consumables to the biotechnology and pharmaceutical industries. The company went public in June 2021 and is headquartered in Hollister, California. Alpha Teknova specializes in manufacturing high-quality reagents that enable the discovery, development, and production of biopharmaceutical products including drug therapies, vaccines, and molecular diagnostics.
Similar companies
Latest newsMore news →
Brett Robertson was elected as a Class II director of Alpha Teknova, Inc., effective June 1, 2026.96d agoJ. Matthew Mackowski was elected as a Class II director of Alpha Teknova, Inc., effective June 1, 2026.96d agoIrene Davis departed as a member of the Board of Directors and the Nominating and Corporate Governance Committee of Alpha Teknova, Inc.96d ago